Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2026-06-04 16:00:49 ET · period of report 2026-06-03 · accession 0001193125-26-257344 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-04 16:00 | 2026-06-03 | TEVA | Shields Matthew | EVP, Gbl Ops | M - OptEx | — | +16.2K | 26.2K | +162% | — |
| DT | 2026-06-04 16:00 | 2026-06-03 | TEVA | Shields Matthew | EVP, Gbl Ops | S - Sale+OE | $32.87 | -16.2K | 9,989 | -62% | -$532.3K |
| DT | 2026-06-04 16:00 | 2026-06-03 | TEVA | Shields Matthew | EVP, Gbl Ops | M - OptEx | $0.00 | -16.2K | 32.4K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-03 | M | A | 16,195 | — | 26,184 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2026-06-03 | S | D | 16,195 | $32.87 | 9,989 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025. (F4) Represents with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting. |
| 3 | Derivative | Restricted Share Units | 2026-06-03 | M | D | 16,195 | $0.00 | 32,392 | D | — · — to — | 16,195 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on June 3, 2024, with 16,195 vested on each of June 3, 2025 and June 3, 2026, 16,195 vesting on June 3, 2027, and 16,197 vesting on June 3, 2028. (F5) Restricted share units were granted on June 3, 2024, with 16,195 vested on each of June 3, 2025 and June 3, 2026, 16,195 vesting on June 3, 2027, and 16,197 vesting on June 3, 2028. (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |